Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Johnson L, Manzardo AM, Miller JL, Driscoll DJ, Butler MG
In recent years, the drugs have transitioned from being solely for type 2 diabetes treatment to increasing use as weight loss drugs, with Novo Nordisks Wegovy and Eli Lillys Zepbound being developed specifically for that purpose
The lapse went largely unnoticed until it was recently highlighted by Derek Lowe in Science, where he described it as an eyebrow-raising moment for a company with so much at stake
Even with manufacturer coupons or savings programs, the brand-name versions remain substantially more expensive than compounded alternatives
The high variability in outcomes, tone of reviews, and marketing model suggest that prospective patients should proceed thoughtfully and weigh both the pros and cons before signing up
30074-7/asset/5367a357-b6ae-4d9a-9e38-d2422800e400/main.assets/gr3_lrg.jpg)
30194-9/asset/e2a34f3b-6f8a-425f-9e34-2cf394cbb616/main.assets/gr4_lrg.jpg)
00459-9/asset/e4c0896a-ac7a-460c-8a8f-e5b97bab8187/main.assets/gr2_lrg.jpg)